Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism - PubMed (original) (raw)

Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism

Nai Yang Fu et al. Mol Cell. 2009.

Free article

Abstract

Although mRNAs of multiple isoforms of Bax, which encodes a central regulator of apoptosis signaling, have been reported, only Baxalpha protein has been well documented and studied. Baxalpha exists in latent form and is activated upon apoptosis induction through conformational changes. Here we demonstrate that Baxbeta protein is ubiquitously present among human cells, but its activity is restricted through stringent regulation by proteasomal degradation. In contrast to Baxalpha, native Baxbeta spontaneously integrates into mitochondrial membrane and is highly potent in inducing cytochrome c release from mitochondria. Remarkably, Baxbeta protein is upregulated by apoptotic stimuli via inhibition of its ubiquitination process, and stable expression of Baxbeta in HCT116-Bax(-/-) cells restores their sensitivity to multiple stimuli. Baxbeta associates with and promotes Baxalpha activation. Moreover, selective knockdown of Baxbeta desensitizes HCT116-Bax(+/-) cells to Bax-dependent apoptosis signaling. These observations underscore the plasticity of human Bax in serving its role as a "gatekeeper" for apoptosis.

PubMed Disclaimer

Comment in

Deadly splicing: Bax becomes Almighty.
Kim H, Hsieh JJ, Cheng EH. Kim H, et al. Mol Cell. 2009 Jan 30;33(2):145-6. doi: 10.1016/j.molcel.2009.01.004. Mol Cell. 2009. PMID: 19187757

Cited by

Alternative production of pro-death Bax∆2 protein via ribosomal frameshift in Alzheimer's disease.
Yao Q, Mañas A, Beatty E, Dos Santos ACM, Zhou Y, Juárez O, Chen H, Xiang J. Yao Q, et al. Sci Rep. 2024 Nov 8;14(1):27288. doi: 10.1038/s41598-024-76061-1. Sci Rep. 2024. PMID: 39516502
Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.
Liu X, Zhang J, Wang Z, Yan M, Xu M, Li G, Shender V, Wei JJ, Li J, Shao C, Zhang S, Kong B, Song K, Liu Z. Liu X, et al. Adv Sci (Weinh). 2024 Apr;11(15):e2306229. doi: 10.1002/advs.202306229. Epub 2024 Feb 11. Adv Sci (Weinh). 2024. PMID: 38342602 Free PMC article.
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths.
Cortés-López M, Chamely P, Hawkins AG, Stanley RF, Swett AD, Ganesan S, Mouhieddine TH, Dai X, Kluegel L, Chen C, Batta K, Furer N, Vedula RS, Beaulaurier J, Drong AW, Hickey S, Dusaj N, Mullokandov G, Stasiw AM, Su J, Chaligné R, Juul S, Harrington E, Knowles DA, Potenski CJ, Wiseman DH, Tanay A, Shlush L, Lindsley RC, Ghobrial IM, Taylor J, Abdel-Wahab O, Gaiti F, Landau DA. Cortés-López M, et al. Cell Stem Cell. 2023 Sep 7;30(9):1262-1281.e8. doi: 10.1016/j.stem.2023.07.012. Epub 2023 Aug 14. Cell Stem Cell. 2023. PMID: 37582363 Free PMC article.
What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?
Brinkmann K, Ng AP, de Graaf CA, Strasser A. Brinkmann K, et al. Cell Death Differ. 2022 Jun;29(6):1079-1093. doi: 10.1038/s41418-022-00987-0. Epub 2022 Apr 6. Cell Death Differ. 2022. PMID: 35388168 Free PMC article. Review.
Physiological Functions of Mcl-1: Insights From Genetic Mouse Models.
Chin HS, Fu NY. Chin HS, et al. Front Cell Dev Biol. 2021 Jul 16;9:704547. doi: 10.3389/fcell.2021.704547. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34336857 Free PMC article. Review.

Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism - PubMed (original) (raw)